Literature DB >> 2419781

Estrous cycle variations in cholecystokinin and substance P concentrations in discrete areas of the rat brain.

M Frankfurt, R A Siegel, I Sim, W Wuttke.   

Abstract

Cholecystokinin (CCK) and substance P (SP) were measured in discrete areas of the rat brain at different stages of the estrous cycle. Significantly higher levels of CCK were found in the lateral septum during diestrus as compared to proestrus. In the parietal cortex, CCK concentrations were significantly higher in diestrus than in proestrus. In the amygdala, estrous levels of CCK were significantly higher than proestrous levels. SP concentrations were significantly higher in diestrus than in proestrus in the medial and lateral septum, and the medial and lateral preoptic area. In the amygdala and ventral tegmental area, SP concentrations were significantly higher in estrus than in proestrus. These data suggest that certain CCK and SP neuronal systems may play a role in regulating the hypothalamo-pituitary-gonadal axis and/or be involved in steroid-dependent behavior.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419781     DOI: 10.1159/000124444

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  3 in total

1.  Effect of nitrous oxide on the concentrations of opioid peptides, substance P, and LHRH in the brain and beta-endorphin in the pituitary.

Authors:  G Kugel; M Zive; R K Agarwal; J R Beumer; A M Kumar
Journal:  Anesth Prog       Date:  1991 Nov-Dec

2.  Castration reversibly alters levels of cholecystokinin immunoreactivity within cells of three interconnected sexually dimorphic forebrain nuclei in the rat.

Authors:  R B Simerly; L W Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Preprotachykinin gene expression in the mediobasal hypothalamus of estrogen-treated and ovariectomized control rats.

Authors:  G J Romano; T I Bonner; D W Pfaff
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.